Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

<p>Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in the young. Acute myocardial ischaemia (a sudden myocardial blood supply/demand mismatch) and pre-existing chronic ionic remodelling (which causes slowed cellular repolarisation) are acknowledged as two key contr...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Coleman, JA
Altri autori:	Bueno Orovio, A
Natura:	Tesi
Lingua:	English
Pubblicazione:	2024
Soggetti:	Computer simulation

Documenti analoghi

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
di: Coleman, J
Pubblicazione: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
di: Coleman, JA, et al.
Pubblicazione: (2023)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
di: Chow, J, et al.
Pubblicazione: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
di: Ji-Jian Chow, et al.
Pubblicazione: (2024-08-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
di: James A. Coleman, et al.
Pubblicazione: (2024-04-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
di: Coleman, JA, et al.
Pubblicazione: (2024)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
di: Coleman, J, et al.
Pubblicazione: (2023)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
di: Zakariye Ashkir, MD, et al.
Pubblicazione: (2024-01-01)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
di: George Joy, MD, et al.
Pubblicazione: (2024-01-01)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
di: Lyon, A, et al.
Pubblicazione: (2018)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
di: Passini, E, et al.
Pubblicazione: (2015)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
di: Safa Daghem, et al.
Pubblicazione: (2024-01-01)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
di: Coleman, JA, et al.
Pubblicazione: (2024)

Functional assessment of myocardial ischaemia by intracoronary ECG
di: Christian Seiler, et al.
Pubblicazione: (2021-02-01)

Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
di: Yan Dong, et al.
Pubblicazione: (2024-05-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
di: Ashrafian, H, et al.
Pubblicazione: (2001)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
di: Raman, B, et al.
Pubblicazione: (2017)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
di: Raman, B, et al.
Pubblicazione: (2018)

Computational detection of electrophysiological abnormalities in hypertrophic cardiomyopathy for risk stratification
di: Lyon, A
Pubblicazione: (2017)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
di: Kramer, CM, et al.
Pubblicazione: (2018)

ECG diagnosis of acute ischaemia and infarction: past, present and future.
di: Herring, N, et al.
Pubblicazione: (2006)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
di: S. M. Komissarova, et al.
Pubblicazione: (2021-05-01)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
di: Doste, R, et al.
Pubblicazione: (2022)

Insights into mechanisms and clinical implications of myocardial fibrosis and its progression in hypertrophic cardiomyopathy
di: Raman, B
Pubblicazione: (2019)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
di: Pal, N
Pubblicazione: (2015)

HYPERTROPHIC CARDIOMYOPATHY AND MYOCARDIAL CRYPT OF THE LEFT VENTRICLE
di: Yu. V. Frolova, et al.
Pubblicazione: (2017-02-01)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
di: Dai Qinyi, et al.
Pubblicazione: (2010-11-01)

Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy
di: Linda T. Aaserud, MD, et al.
Pubblicazione: (2024-10-01)

Application of cardiac electrophysiology simulations to pro−arrhythmic safety testing
di: Mirams, G, et al.
Pubblicazione: (2012)

Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.
di: Mirams, G, et al.
Pubblicazione: (2012)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
di: K. A. Skiba, et al.
Pubblicazione: (2003-06-01)

Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischemia and its modulation by sodium current availability
di: Martinez-Navarro, H, et al.
Pubblicazione: (2020)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
di: Ashrafian, H, et al.
Pubblicazione: (2003)

An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
di: Danny A. J. P. van de Sande, et al.
Pubblicazione: (2014-01-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
di: D. V. Bogdanov
Pubblicazione: (2015-05-01)

The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
di: Patryk Skórka, et al.
Pubblicazione: (2025-02-01)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
di: Coppini, R, et al.
Pubblicazione: (2019)

On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy
di: I. A. Miroshkina, et al.
Pubblicazione: (2021-09-01)

HYPERTROPHIC CARDIOMYOPATHY: MODERN APPROACHES TO DIAGNOSIS AND TREATMENT
di: Elena S. Eniseeva
Pubblicazione: (2024-09-01)

Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
di: M. S. Bychkova, et al.
Pubblicazione: (2023-10-01)